Abdullah Esmail
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Viral-associated cancers and disorders
Papers in
- Co-authors
- Maen Abdelrahim (58 shared papers)Ashish Saharia (21 shared papers)Rafik M. Ghobrial (14 shared papers)Ala Abudayyeh (13 shared papers)David W. Victor (10 shared papers)Sudha Kodali (12 shared papers)Robert McMillan (7 shared papers)Naoka Murakami (4 shared papers)
- Journals
- Cancers (13 papers)Journal of Clinical Oncology (12 papers)Annals of Oncology (9 papers)Frontiers in Pharmacology (3 papers)Frontiers in Oncology (3 papers)
- Partner nations
- United StatesJordanSaudi Arabia
In The Last Decade
Abdullah Esmail
59 papers receiving 454 citations
Peers
Comparison fields: 5 of 44
- Hepatology 147
- Oncology 217
- Transplantation 19
- Cancer Research 96
- Surgery 191
Countries citing papers authored by Abdullah Esmail
This map shows the geographic impact of Abdullah Esmail's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdullah Esmail with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdullah Esmail more than expected).
Fields of papers citing papers by Abdullah Esmail
This network shows the impact of papers produced by Abdullah Esmail. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdullah Esmail. The network helps show where Abdullah Esmail may publish in the future.
Co-authors
The 25 scholars most cited alongside Abdullah Esmail, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 44 | |
| 2 | 2022 | 36 | |
| 3 | 2022 | 35 | |
| 4 | 2022 | 31 | |
| 5 | 2022 | 22 | |
| 6 | 2024 | 19 | |
| 7 | 2022 | 18 | |
| 8 | 2022 | 17 | |
| 9 | 2022 | 16 | |
| 10 | 2022 | 15 | |
| 11 | 2022 | 14 | |
| 12 | 2022 | 14 | |
| 13 | 2022 | 12 | |
| 14 | 2023 | 12 | |
| 15 | 2022 | 11 | |
| 16 | 2023 | 10 | |
| 17 | 2024 | 9 | |
| 18 | 2024 | 8 | |
| 19 | 2021 | 8 | |
| 20 | 2021 | 7 |
About Abdullah Esmail
Abdullah Esmail is a scholar working on Oncology, Surgery, Hepatology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 67 papers that have together received 457 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (22 papers), Hepatocellular Carcinoma Treatment and Prognosis (21 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (16 papers), Pancreatic and Hepatic Oncology Research (14 papers), Cancer Immunotherapy and Biomarkers (9 papers), Viral-associated cancers and disorders (7 papers), Hepatitis B Virus Studies (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). The work is most often cited by research in Hepatology (147 citations), Oncology (217 citations), Transplantation (19 citations), Cancer Research (96 citations) and Surgery (191 citations). Abdullah Esmail has collaborated with scholars based in United States, Jordan and Saudi Arabia. Frequent co-authors include Maen Abdelrahim, Ashish Saharia, Rafik M. Ghobrial, Ala Abudayyeh, David W. Victor, Sudha Kodali, Robert McMillan, Naoka Murakami, Kirk Heyne and Jenny C. Chang. Their work appears in journals such as Cancers, Journal of Clinical Oncology, Annals of Oncology, Frontiers in Pharmacology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.